FRASCHINI, FRANCO LUIGI
FRASCHINI, FRANCO LUIGI
DIPARTIMENTO DI FARMACOLOGIA, CHEMIOTERAPIA E TOSSICOLOGIA MEDICA (attivo dal 01/01/1960 al 26/04/2012)
Melatonin reduces the need for sedation in ICU patients: A randomized controlled trial
2015 G. Mistraletti, M. Umbrello, G. Sabbatini, S. Miori, M. Taverna, B. Cerri, E.S. Mantovani, P. Formenti, P. Spanu, A. D'Agostino, S. Salini, A. Morabito, F. Fraschini, R.J. Reiter, G. Iapichino
Melatonin reduces the need for sedation in ICU patients : a randomized controlled trial
2015 G. Mistraletti, M. Umbrello, G. Sabbatini, S. Miori, M. Taverna, B. Cerri, E.S. Mantovani, P. Formenti, P. Spanu, A. D'Agostino, S. Salini, A. Morabito, F. Fraschini, R.J. Reiter, G. Iapichino
Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways
2015 M. Lopez Canul, E. Palazzo, S. Dominguez Lopez, L. Luongo, B. Lacoste, S. Comai, D. Angeloni, F. Fraschini, S. Boccella, G. Spadoni, A. Bedini, G. Tarzia, S. Maione, V. Granados Soto, G. Gobbi
Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain
2015 B. Lacoste, D. Angeloni, S. Dominguez Lopez, S. Calderoni, A. Mauro, F. Fraschini, L. Descarries, G. Gobbi
Antitumour activity of melatonin in a mouse model of human prostate cancer : relationship with hypoxia signalling
2014 R. Paroni, L. Terraneo, F. Bonomini, E. Finati, E. Virgili, P. Bianciardi, G. Favero, F. Fraschini, R.J. Reiter, R. Rezzani, M. Samaja
Melatonin : positive effects on high-risk patients with desynchronized sleep-wake rhythm
2013 E. Finati, G. Mistraletti, G. Iapichino, F. Fraschini, R. Paroni
Suprachiasmatic nucleus neuropeptide expression in patients with Huntington's Disease
2013 D.J. van Wamelen, N.A. Aziz, J.J. Anink, R. van Steenhoven, D. Angeloni, F. Fraschini, R. Jockers, R.A. Roos, D.F. Swaab
Pharmacokinetics of oral melatonin in high-risk critically ill : standard formulation vs incapsulation in solid lipid nanoparticles (SLN)
2012 B. Salihovic, F. Ferrari, G. Mistraletti, E. Mantovani, R.C. Paroni, E. Finati, F.L. Fraschini, I. Galluccio, B. Cerri, S. Marzorati, G. Iapichino
Anxiolytic effects of the melatonin MT2 receptor partial agonist UCM765 : Comparison with melatonin and diazepam
2012 R. Ochoa Sanchez, Q. Rainer, S. Comai, G. Spadoni, A. Bedini, S. Rivara, F. Fraschini, M. Mor, G. Tarzia, G. Gobbi
Symptomatic Spinal Degenerative Pathologies: Clinical Results with the Application of Conservative Biochemical Treatments
2012 A. Alexandre, L. Coro, R. Paradiso, R. Dall'Aglio, A.M. Alexandre, F. Fraschini, P.G. Spaggiari
Effetti clinici della melatonina nei pazienti critici ad alto rischio
2011 G. Mistraletti, M. Tozzi, S. Miori, G. Sabbatini, B. Salihovic, B. Cerri, S. Salini, A. Morabito, F.L. Fraschini, G. Iapichino
Treatment of symptomatic lumbar spinal degenerative pathologies by means of combined conservative biochemical treatments
2011 A. Alexandre, L. Corò, R. Paradiso, R. Dall'Aglio, A.M. Alexandre, F. Fraschini, P.G. Spaggiari
Promotion of Non-Rapid Eye Movement Sleep and Activation of Reticular Thalamic Neurons by a Novel MT2 Melatonin Receptor Ligand
2011 R. Ochoa Sanchez, S. Comai, B. Lacoste, F. Rodriguez Bambico, S. Dominguez Lopez, G. Spadoni, S. Rivara, A. Bedini, D. Angeloni, F. Fraschini, M. Mor, G. Tarzia, L. Descarries, G. Gobbi
La melatonina riduce la necessità di sedativi e di analgesici in pazienti critici ad alto rischio
2011 G. Mistraletti, M. Taverna, S. Miori, M. Tozzi, L. D’Amato, B. Cerri, S. Salini, A. Morabito, F.L. Fraschini, G. Iapichino
LNCaP Prostate Cancer Growth In Vivo : Oncostatic Effects of Melatonin as compared to Hypoxia and Reoxygenation
2011 L. Terraneo, E. Finati, E. Virgili, G. Demartini, L. De Angelis, R. Dall'Aglio, F.L. Fraschini, M. Samaja, R.C. Paroni
Erratum: The natural antioxidant alpha-lipoic acid induces p27Kip1-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells (European Journal of Pharmacology (2010) 641 (29-34))
2011 E. Dozio, M. Ruscica, L. Passafaro, G. Dogliotti, L. Steffani, P. Marthyn, A. Pagani, G. Demartini, D. Esposti, F. Fraschini, P. Magni
The natural antioxidant alpha-lipoic acid induces p27(Kip1)-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells
2010 E. Dozio, M. Ruscica, L. Passafaro, G. Dogliotti, L. Steffani, A. Pagani, G. Demartini, D. Esposti, F. Fraschini, P. Magni
Pharmacokinetics of orally administered melatonin in critically ill patients
2010 G. Mistraletti, G. Sabbatini, M. Taverna, M.A. Figini, M. Umbrello, P. Magni, M. Ruscica, E. Dozio, R. Esposti, G. Demartini, F. Fraschini, R. Rezzani, R.J. Reiter, G. Iapichino
Melatonin delivery in solid lipid nanoparticles : prevention of cyclosporine A induced cardiac damage
2009 R. Rezzani, L.F. Rodella, F. Fraschini, M.R. Gasco, G. Demartini, C. Musicanti, R.J. Reiter
Synthesis, enantiomeric resolution, and structure-activity relationship study of a series of 10,11-dihydro-5H-dibenzo[a,d]cycloheptene MT2 receptor antagonists
2007 G. Spadoni, A. Bedini, G. Diamantini, G. Tarzia, S. Rivara, S. Lorenzi, A. Lodola, M. Mor, V. Lucini, M. Pannacci, A. Caronno, F. Fraschini